+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

OTC Consumer Health Products Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • ID: 5557611
  • Report
  • February 2022
  • Region: Global
  • 100 Pages
  • Infinium Global Research
The report on the global OTC consumer health products market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global OTC consumer health products market to grow with a CAGR of 4% over the forecast period from 2021-2027. The study on OTC consumer health products market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.



The report on OTC consumer health products market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global OTC consumer health products market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global OTC consumer health products market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings


1) Drivers

  • Rising awareness of lifestyle diseases in the people
  • Increasing disposable income of the consumers

2) Restraints

  • Presence of counterfeit medicines and other counterfeit consumer health products in market

3) Opportunities

  • Rising penetration of internet and growing promotional activities

Research Methodology


A) Primary Research


Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research


Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global OTC consumer health products market is segmented on the basis of type, and distribution channel.

The Global OTC Consumer Health Products Market by Type

  • Skin Care Products
  • Nutritional Supplements
  • Oral Care Products
  • Wound Care Management Products
  • Gastrointestinal Products
  • Others

The Global OTC Consumer Health Products Market by Distribution Channel

  • Hospital Pharmacy
  • Independent Pharmacies
  • Departmental Stores
  • Online Sales
  • Other

Company Profiles


The companies covered in the report include
  • Pfizer, Inc.
  • Sanofi S.A
  • Bayer AG
  • American Health
  • Glenmark Pharmaceuticals Ltd.
  • Piramal Enterprises Ltd.
  • Johnson & Johnson
  • GlaxosmithKline plc
  • Sun Pharmaceuticals Ltd.
  • Abbott Laboratories

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the OTC consumer health products market.
2. Complete coverage of all the segments in the OTC consumer health products market to analyze the trends, developments in the global market and forecast of market size up to 2027.
3. Comprehensive analysis of the companies operating in the global OTC consumer health products market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Frequently Asked Questions about the Global OTC Consumer Health Products Market

What is the estimated value of the Global OTC Consumer Health Products Market?

The Global OTC Consumer Health Products Market was estimated to be valued at $179.6 Billion in 2021.

What is the growth rate of the Global OTC Consumer Health Products Market?

The growth rate of the Global OTC Consumer Health Products Market is 4.3%, with an estimated value of $231.7 Billion by 2027.

What is the forecasted size of the Global OTC Consumer Health Products Market?

The Global OTC Consumer Health Products Market is estimated to be worth $231.7 Billion by 2027.

Who are the key companies in the Global OTC Consumer Health Products Market?

Key companies in the Global OTC Consumer Health Products Market include Pfizer, Inc., Sanofi S.A, Bayer AG, American Health, Glenmark Pharmaceuticals Ltd., Piramal Enterprises Ltd., Johnson & Johnson, GlaxosmithKline plc and Abbott Laboratories.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. OTC Consumer Health Products Market Highlights
2.2. OTC Consumer Health Products Market Projection
2.3. OTC Consumer Health Products Market Regional Highlights
3. Global OTC Consumer Health Products Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the OTC Consumer Health Products Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Type
3.5.2. Growth Matrix Analysis by Distribution Channel
3.5.3. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of OTC Consumer Health Products Market
4. OTC Consumer Health Products Market Macro Indicator Analysis
5. Global OTC Consumer Health Products Market by Type
5.1. Skin Care Products
5.2. Nutritional Supplements
5.3. Oral Care Products
5.4. Wound Care Management Products
5.5. Gastrointestinal Products
5.6. Others
6. Global OTC Consumer Health Products Market by Distribution Channel
6.1. Hospital Pharmacy
6.2. Independent Pharmacies
6.3. Departmental Stores
6.4. Online Sales
6.5. Other
7. Global OTC Consumer Health Products Market by Region 2021-2027
7.1. North America
7.1.1. North America OTC Consumer Health Products Market by Type
7.1.2. North America OTC Consumer Health Products Market by Distribution Channel
7.1.3. North America OTC Consumer Health Products Market by Country
7.2. Europe
7.2.1. Europe OTC Consumer Health Products Market by Type
7.2.2. Europe OTC Consumer Health Products Market by Distribution Channel
7.2.3. Europe OTC Consumer Health Products Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific OTC Consumer Health Products Market by Type
7.3.2. Asia-Pacific OTC Consumer Health Products Market by Distribution Channel
7.3.3. Asia-Pacific OTC Consumer Health Products Market by Country
7.4. RoW
7.4.1. RoW OTC Consumer Health Products Market by Type
7.4.2. RoW OTC Consumer Health Products Market by Distribution Channel
7.4.3. RoW OTC Consumer Health Products Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global OTC Consumer Health Products Market
8.2. Companies Profiled
8.2.1. Pfizer, Inc.
8.2.2. Sanofi S.A
8.2.3. Bayer AG
8.2.4. American Health
8.2.5. Glenmark Pharmaceuticals Ltd.
8.2.6. Piramal Enterprises Ltd.
8.2.7. Johnson & Johnson
8.2.8. GlaxosmithKline plc
8.2.9. Sun Pharmaceuticals Ltd.
8.2.10. Abbott Laboratories

Companies Mentioned

  • Pfizer, Inc.
  • Sanofi S.A
  • Bayer AG
  • American Health
  • Glenmark Pharmaceuticals Ltd.
  • Piramal Enterprises Ltd.
  • Johnson & Johnson
  • GlaxosmithKline plc
  • Sun Pharmaceuticals Ltd.
  • Abbott Laboratories